| Business Summary | | Markel
Corporation
markets
and
underwrites
specialty
insurance
products
and
programs
to
a
variety
of
niche
markets.
The
Company
competes
in
four
distinct
areas
of
the
specialty
insurance
market.
Markel
North
America
competes
domestically
in
the
Excess
and
Surplus
Lines
Market
(E&S
Market)
and
the
Specialty
Admitted
Market.
Markel
International
competes
in
the
London
Company
Market
and
the
Lloyd's
Market.
Four
of
the
Company's
underwriting
units,
Essex
Excess
and
Surplus
Lines,
Professional/Products
Liability,
Brokered
Excess
and
Surplus
Lines,
and
Markel
Southwest
Underwriters,
write
in
the
E&S
Market.
Two
of
the
Company's
underwriting
units,
Specialty
Program
Insurance
and
Specialty
Personal
and
Commercial
Lines,
write
in
the
Specialty
Admitted
Market.
The
Company
participates
in
the
London
Company
Market
through
Terra
Nova.
The
Company
participates
in
the
Lloyd's
Market
through
its
corporate
capital
provider,
Markel
Capital,
in
four
Lloyd's
syndicates. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Markel
Corporation
markets
and
underwrites
specialty
insurance
products
and
programs
including
excess
and
surplus
lines
and
specialty
personal
and
commercial
lines.
For
the
six
months
ended
6/30/01,
revenues
increased
36%
to
$632.8
million.
Net
income
totalled
$9
million
vs.
a
loss
of
$3.7
million.
Revenues
reflect
acquisitions
and
growth
in
premiums
earned.
Earnings
also
reflect
decreased
underwriting
expenses
as
a
percentage
of
revenues. | More
from
Market Guide: Significant
Developments |
| | | | FY1998
Compensation | | Pay | Exer | |
| Alan Kirshner, 63 Chairman,
CEO, Director | $785K | -- | Anthony Markel, 56 Pres,
COO, Director | 745K | -- | Steven Markel, 50 Vice
Chairman, Director | 725K | $1.3M | Darrell Martin, 50 Exec.
VP, CFO, Director | 552K | 3.3M | Leslie Grandis, 54 Sec.,
Director | -- | -- | Dollar
amounts are as of 31-Dec-1998 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|